What do US Businesses that Deploy Third-Party Generative AI need to know about the EU AI Act?

What do US Businesses that Deploy Third-Party Generative AI need to know about the EU AI Act?

Executive Summary (What U.S. Businesses Must Know Immediately)

Even if your company is based entirely in the U.S., you are legally subject to the EU AI Act if you deploy or use third‑party generative AI and the outputs are used in the EU, or if EU users can access your AI‑enabled services. The Act applies extraterritorially, just like GDPR.

This means U.S. companies must understand their role (provider vs. deployer), the risk category of the AI they use, and the compliance obligations that apply — even when the AI model itself is built by OpenAI or Microsoft.

🧭 1. The EU AI Act Applies to U.S. Companies Even Without an EU Office

The Act applies to:

  • Any provider placing an AI system or service on the EU market
  • Any deployer (user) of AI whose outputs are used in the EU
  • Any company whose AI tools are accessible to EU users, even if hosted in the U.S.

This includes:

  • U.S. companies using Microsoft Copilot internally if outputs affect EU operations
  • U.S. SaaS platforms that integrate OpenAI APIs and have EU customers
  • U.S. firms whose employees in the EU use generative AI tools
  • U.S. companies whose AI‑generated content is used in EU decision‑making

🧩 2. Your Company’s Obligations Depend on Your Role

The EU AI Act distinguishes between:

  1. Providers

You are a provider if you:

  • Integrate OpenAI, Copilot, or other models into your own product
  • Offer AI‑enabled features to EU customers
  • Fine‑tune or customize a model and deploy it to EU users

Providers have the heaviest obligations (documentation, risk management, transparency, CE marking for high‑risk systems).

  1. Deployers (Users)

You are a deployer if you:

  • Use third‑party generative AI internally (e.g., Copilot for employees)
  • Use AI outputs in workflows that affect EU individuals

Deployers have obligations around:

  • Transparency
  • Human oversight
  • Data governance
  • Fundamental‑rights impact assessments (for high‑risk uses)

Most U.S. businesses using Copilot or OpenAI will be deployers, but many SaaS companies are providers without realizing it.

⚠️ 3. Generative AI (GPAI) Has Its Own Set of Rules

Generative AI models — including GPT‑4, GPT‑4o, Claude, Gemini, and Copilot — fall under the General‑Purpose AI (GPAI) rules.

These rules apply 12 months after entry into force (July 2025).

If you are a deployer of GPAI (most U.S. businesses):

You must ensure:

  • You do not use GPAI in prohibited ways
  • You follow transparency obligations (e.g., labeling AI‑generated content)
  • You implement human oversight
  • You manage risks when AI outputs affect EU individuals

If you are a provider of GPAI‑enabled features:

You must ensure:

  • You only use GPAI models that meet EU documentation and transparency requirements
  • You provide downstream users with required information
  • You monitor and mitigate systemic risks (for powerful models)

🚫 4. You Must Not Use Generative AI in Prohibited Ways

The EU AI Act bans certain uses of AI outright.
These prohibitions took effect 6 months after entry into force (February 2025).

U.S. businesses must ensure they do not use generative AI for:

  • Manipulative or deceptive behavior‑distorting techniques
  • Exploiting vulnerable groups
  • Social scoring
  • Predicting criminality of individuals
  • Emotion recognition in workplaces or schools
  • Untargeted scraping of facial images
  • Biometric categorization (e.g., inferring race or sexual orientation)

If your company uses Copilot or OpenAI in HR, marketing, or security workflows, you must ensure none of these prohibited uses occur.

🟧 5. High‑Risk AI Rules May Apply If You Use AI in Sensitive Areas

Even if you rely on third‑party models, your use case may be classified as high‑risk under Annex III.

Examples relevant to U.S. companies:

  • Using AI for hiring or employee evaluation
  • Using AI for creditworthiness or fraud scoring
  • Using AI for education, testing, or admissions
  • Using AI in healthcare or medical devices
  • Using AI in critical infrastructure
  • Using AI in law enforcement‑adjacent contexts

High‑risk obligations begin 24 months after entry into force (August 2026).

If your use case is high‑risk, you must implement:

  • Risk‑management systems
  • Logging and traceability
  • Human oversight
  • Data governance
  • Accuracy and robustness controls
  • Conformity assessments (if you are a provider)

🧱 6. You Cannot Rely on OpenAI or Microsoft Alone for Compliance

This is a major misconception.

Even if the model provider (OpenAI, Microsoft, Anthropic) complies with the Act, your company still has independent obligations, including:

  • Ensuring your use case is not prohibited
  • Ensuring your deployment meets transparency and oversight rules
  • Conducting impact assessments (for high‑risk uses)
  • Ensuring AI outputs are not used unlawfully in the EU
  • Keeping documentation for regulators

The Act explicitly applies to deployers, not just model developers.

🧭 7. Key Questions Every U.S. Business Must Ask

  1. Do we have EU users, customers, employees, or operations?
  2. Do any AI outputs affect EU individuals?
  3. Are we a provider or deployer?
  4. Are we using AI in any high‑risk areas?
  5. Are we using AI in any prohibited ways?
  6. Do we rely on third‑party models in ways that create new risks?
  7. Do we have documentation and oversight processes in place?

📌 Bottom Line

If your U.S. business uses generative AI from OpenAI, Microsoft Copilot, or any other vendor — and your AI outputs touch the EU in any way — you are likely legally subject to the EU AI Act.

You must:

  • Avoid prohibited uses
  • Follow GPAI transparency rules
  • Assess whether your use case is high‑risk
  • Implement oversight and documentation
  • Understand your role (provider vs. deployer)
  • Prepare for enforcement beginning in 2025–2026

The Act’s extraterritorial reach means compliance is not optional for U.S. companies with EU exposure.



Leave a Reply